We are delighted to have announced the first International Neuroblastoma Research Initiative award to be funded under our AMRC-accredited research funding process, which will see a targeted drug introduced to frontline treatment for children with the hope of dramatically increasing survival rates. Read more
This Autumn we are extremely busy with our ongoing International Neuroblastoma Research Initiatives. Read more
The impact of COVID-19 has been serious and will have long-lasting consequences for medical research in the UK, not least because so much of our medical research is funded by charities. Read more
Solving Kids' Cancer (US and UK) together with the Max Cure Foundation hosted a webinar on the impact of the current pandemic on the paediatric oncology research landscape. Read more
The coronavirus pandemic has brought new challenges to our ongoing research programme, as we work with experts worldwide to bring more, better and less toxic treatment to children in the UK and beyond. Read more